“These findings suggest that primordial and primary interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD," wrote the study authors.
A study recently published in JAMA Network found that children who resolved dyslipidemic non-high-density lipoprotein cholesterol (non-HDL-C) by adulthood have similar risk of cardiovascular disease (CVD) events with those who never had dyslipidemia. This suggests interventions to prevent and reduce elevated non-HDL-C levels could prevent premature CVD.
To determine associations of non-HDL-C status among childhood and adulthood with CVD events, investigators pooled individual data of 6 prospective cohorts of children in the United States and Finland. Mean age at baseline was 10.7 years, and recruitment took place from 1970 to 1996, with a final follow-up in 2019.
After all exclusion/inclusion criteria, 5121 participants were included in the primary analysis. Standardized questionnaires and laboratory protocols were used to collect childhood (aged 3 to 19 years) and adulthood (aged 20 years or older) information for:
- Total cholesterol and HDL-C levels from fasting samples
- Age
- Sex
- Smoking habits
- Lipid-lowering medications
- Type 2 diabetes
- Blood pressure
- Body mass index
Non-HDL-C measurements taken between ages 20 and 40 years were used to define adulthood non-HDL-C exposures. The childhood non-HDL-C levels at each visit were standardized as age- and sex-specific z scores because of age-related developmental changes. The mean z scores across childhood measurements for each participant was calculated for a single mean z score for analysis. Single mean z scores were also calculated for adults using the same method.
There were 147 fatal or nonfatal CVD events that occurred among 5121 participants over a mean length of follow-up of 8.9 years after age 40. From childhood to adulthood, 937 (18%) had resolution of dyslipidemia, 252 (5%) had persistent dyslipidemia, 158 (3%) had incident dyslipidemia, and 3774 (74%) had non-HDL-C levels “that were persistently within the guideline-recommended range,” the investigators wrote.
Childhood and adult non-HDL-C z scores were moderately correlated (r = 0.587 [P < .001]). Both childhood and adult non-HDL-C z scores were associated with increased risk of fatal or nonfatal CVD events when analyzed separately (HRs, 1.42 [95% CI, 1.18-1.70] and 1.50 [95% CI, 1.26-1.78] for a 1-unit increase in z score, respectively).
When both childhood and adult z scores were included in the same model, the childhood non-HDL-C z score was reduced ((HR, 1.12 [95% CI, 0.89-1.41]), while the adult z score remained significant (HR, 1.41 [95% CI, 1.14-1.74]).
When both z score and change in non-HDL-C z scores between childhood and adulthood were included in the same model, “childhood non–HDL-C z score remained a significant predictor of the outcome (HR, 1.58 [95% CI, 1.30-1.92]) and the incremental change in the z score was an additional independent predictor (HR, 1.41, [95% CI, 1.14-1.74]),” noted the study authors.
Participants who had incident dyslipidemia had a significantly increased risk of fatal or nonfatal CVD events compared to those with persistently normal non-HDL-C in childhood and adulthood (HR, 2.17 [95% CI, 1.00-4.69]). Those with persistent non-HDL-C dyslipidemia from childhood to adulthood had double that risk (HR, 5.17 [95% CI, 2.80-9.56]).
Overall, results revealed that those with persistent non-HDL-C dyslipidemia from childhood to adulthood had an increased risk of CVD events. Those who had non-HDL-C dyslipidemia resolved by adulthood shared a similar risk as individuals with normal HDL-C in childhood and adulthood, leading the study investigators to conclude, “These findings suggest that primordial and primary interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD.”
Reference:
Wu F, Jacobs DR, Daniels SR, et al. non–high-density lipoprotein cholesterol levels from childhood to adulthood and cardiovascular disease events. JAMA. Published online April 12, 2024. doi:10.1001/jama.2024.4819
Can smartwatch technology identify arrhythmias in children with adult algorithms?
February 28th 2024Scott Ceresnak, MD, explains smartwatch technology could be a great tool in detecting arrhythmias in children, however, given that algorithms in the technology were designed for adults, caution must be used as well.
Maternal folic acid linked to reduced Kawasaki disease risk in infants
January 9th 2024A study revealed that higher maternal folic acid levels and frequent supplementation during pregnancy can significantly lower the risk of Kawasaki disease in infants, highlighting the potential protective role of folic acid.